LADX.US LadRx Corporation

Healthcare Biotechnology USA Stocks
0.0003 USD
Close of Nov 14, 2026
0.0002 0.2000
Market cap
USD 148.00
P/E
-
P/B
3.61x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2025.

Is LADX.US undervalued?

Graham number

The Graham number of LadRx Corporation cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

LadRx Corporation fundamental analysis

No fundamental analysis for LadRx Corporation yet.

LadRx Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About LadRx Corporation

LadRx Corporation, a biopharmaceutical company, engages in research and development of chemotherapeutic drugs for solid tumors in the United States. The company offers linker activated drug releases (LADR) technology, a platform consists of an organic backbone that is attached to a chemotoxic agent that targets and delivers the chemotoxic agent to the tumor environment and release within the tumor. Its lead candidates comprising LADRs 7, 8, 9, and 10 with novel derivatives o…

Full company profile